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Abstract Sex chromosomes in different organisms are
studied as model systems for chromatin regulation of
transcription and epigenetics. Similar to the female X in
mammals, the male X chromosome in Drosophila is
involved in the process of dosage compensation. However,
in contrast to one of the mammalian female X chromo-
somes undergoing inactivation, the Drosophila male X is
transcriptionally upregulated by approximately twofold.
The Drosophila male X is a remarkable example for a
specialized, transcriptionally hyperactive chromatin domain
that facilitates the study of chromatin regulation in the
context of transcription, nuclear architecture, and chromatin
remodeling. In addition, the rich phenomenology of dosage
compensation in Drosophila provides an opportunity to
explore the complexities of gene regulation through
epigenetic chromatin configurations, histone modifications,
and noncoding RNAs. Male-specific lethal (MSL) factors
constitute the MSL complex or dosage compensation
complex and are important for transcription regulation of
X-linked genes. Recent biochemical studies have identified
a number of interesting factors that associate with the MSL
complex including components of the nuclear pore complex
and exosome subunits. Furthermore, global analysis of
MSL complex binding showed that MSL complexes are
enriched on genes with preferential binding to 3′ end of
genes. Taken together, these findings suggest a role of the
MSL complex in transcription elongation, RNA processing,
and/or nuclear organization.
Dosage compensation in Drosophila—a fascinating
story
Different numbers or types of sex chromosomes bring
about the distinction between heterogametic and homoga-
metic individuals. Unequal distribution of chromosomes
normally results in dramatic changes in gene dosage that
can lead to developmental defects or death. Therefore, in
parallel with sex chromosomes, animals have evolved
mechanisms that ensure equalization of gene expression
levels between males and females. These processes evolved
independently several times during evolution, and they are
collectively termed dosage compensation. The mechanisms
of dosage compensation vary largely between different
organisms and involve different molecular factors. Howev-
er, the common theme among all model systems of dosage
compensation, which have been analyzed at the molecular
level, is their regulation at the level of chromatin.
One of the prominent dosage compensation model
systems, which has been genetically and biochemically
studied, is the hyperactive X chromosome in male fruit
flies. Moreover, dosage compensation as a general principle
was first described in Drosophila melanogaster (Bridges
1925). In contrast to mammals (for a review, see Heard and
Disteche 2006), in Drosophila females (XX), both X
chromosomes are actively transcribed. Accordingly, Dro-
sophila males (XY) have to increase their transcription
from the single X chromosome about twofold to compen-
sate for the different gene dosage (see Fig. 1). Molecular
factors that have male-specific lethal (MSL) phenotype
have been genetically identified (for reviews, see Akhtar
2003; Gilfillan et al. 2004; and Lucchesi et al. 2005). Most
of the factors required for dosage compensation in
Drosophila have been found in a series of genetic screens
for mutants that exhibit male-specific lethality (Belote
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The proteins encoded by the male specific lethal genes are
collectively named MSLs and include MSL1, MSL2, MSL3,
MLE (maleless), and MOF (males absent on the first).
Immunofluorescence studies beautifully visualized these
proteins colocalizing on hundreds of sites along the male X
chromosome, suggesting that they might work together at
specific chromosomal sites to promote dosage compensa-
tion (see Fig. 2) (Kuroda et al. 1991; Palmer et al. 1993).
Indeed, biochemical characterization of MSLs confirmed
that they interact physically and form an X-chromosome-
specific MSL complex or the dosage compensation com-
plex (DCC) (Copps et al. 1998; Meller et al. 2000; Mendjan
et al. 2006; Scott et al. 2000; Smith et al. 2000). Moreover,
two noncoding RNAs, roX1 and roX2 (RNA on the X),
colocalize specifically with MSLs on the X (Amrein and
Axel 1997; Meller et al. 1997). The roX1/roX2 double-
mutant flies exhibit an MSL phenotype, and both RNAs
were shown to interact with the MSL complex (Franke and
Baker 1999; Meller and Rattner 2002; Meller et al. 1997;
Smith et al. 2000). MSLs and roX RNAs assemble together
at specific nucleation sites on the X chromosome, which
have various affinities for the MSL complex (Dahlsveen et
al. 2006; Demakova et al. 2003; Kelley et al. 1999).
Thus, the MSL complex is a unique ribonucleoprotein
complex that specifically recognizes the male X chromo-
some and mediates a twofold transcriptional upregulation of
most X-linked genes irrespective of their inherent differ-
ences in expression levels.
Lessons from MSLs—together they are strong
One of the key questions is how does the MSL complex
achieve a twofold increase in transcription on the male X
chromosome?Onewaytogetsomehintsaboutwhatactivities
and molecular mechanismsmight be associated with the MSL
complex is to analyze its components. MSL proteins contain
several domains that are generally implicated in chromatin
regulation. MSL1 is a PEHE domain containing protein,
MSL2 contains a RING finger and a cysteine-rich cluster, and
MSL3containsachromo-barreldomainandanMRGdomain.
MLE and MOF contain enzymatic activities that are associ-
ated with the MSL complex. MLE is an RNA/DNA helicase
also containing a double-stranded RNA binding domain, and
MOF is a histone H4 lysine 16 (H4K16) specific histone
acetyltransferase(HAT),whichinadditiontotheHATdomain
also contains a chromo-barrel domain and a zinc finger
(Fig. 3, Table 1, and references therein). Over the years,
several studies using in vitro and in vivo approaches have
provided a wealth of information about important interaction
regions in MSL proteins as well as roX RNAs. A brief
summary of the mapping studies is provided in Table 1 (also
see Gilfillan et al. 2004; Rea and Akhtar 2006;a n dT a i p a l e
and Akhtar 2005 for reviews). However, despite several in-
depth studies, analysis of MSL proteins continues to provide
us with new and interesting insights about the complex
properties of MSL proteins. Some of the recent advances are
discussed below.
One of the best-characterized proteins of the MSL
complex is the HAT MOF that specifically acetylates lysine
16 on histone H4 (H4K16Ac) on the X chromosome
(Hilfiker et al. 1997). The HAT activity of MOF has been
suggested to directly contribute to the stimulation of
transcription and therefore has a direct impact on dosage
compensation (Akhtar and Becker 2000; Hilfiker et al.
1997). MOF requires to be incorporated into the MSL
complex via interactions with MSL3 and MSL1 to exhibit
its full enzymatic activity (Morales et al. 2004). As
mentioned above besides the HAT domain, MOF contains
a chromo-barrel domain similar to MSL3. Chromo-barrel
Fig. 1 Dosage compensation in Drosophila. Dosage compensation in
Drosophila involves an approximately twofold transcriptional up-
regulation of the single male X chromosome in comparison to female
X chromosomes (a). This is mediated by an RNA/protein MSL
complex or dosage compensation complex (DCC) which is composed
of at least five proteins: MSL1, MSL2, MSL3, MOF, and MLE, and
two noncoding RNAs roX1 and roX2 (b). The MSL complex is
responsible for hyperacetylation of histone H4 lysine 16 (H4K16) on
the male X chromosome
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been shown to bind methylated histones, DNA, and RNA
(Bernstein et al. 2006; Bouazoune et al. 2002; Flanagan et
al. 2005; Min et al. 2003). Chromodomains comprise an
essential part of the histone code hypothesis that explains
transcriptional regulation through binding and recruitment
of specific regulators dependent on specific combinations
of histone modifications (Strahl and Allis 2000). Therefore,
the question arises if these domains contribute to something
like an X chromosomal histone code. The structure of the
MOF chromo-barrel domain has revealed that this domain
(also present in MSL3) is structurally distinct from the
canonical chromodomains found in numerous chromatin-
related proteins (Nielsen et al. 2005). MOF chromo-barrel
domain is composed of β-barrels, while the canonical
chromodomains have an α+β fold. It is interesting to note
that this structure resembles the HP1 chromodomain bound
to methylated histone H3 lysine 9 (H3K9) (Nielsen et al.
2002), suggesting that the MOF chromo-barrel domain
would not be able to accommodate a methylated histone
tail. This poses an interesting question as to the function of
MOF chromo-barrel domain. The MOF chromo-barrel
domain and its adjacent lysine-rich region are required for
RNA binding in vitro (Akhtar et al. 2000; Nielsen et al.
2005). It remains to be seen how this region of MOF
mechanistically participates in RNA interaction and wheth-
er the chromo-barrel domain may also be able to recognize
some other histone modifications.
In contrast to MOF, the chromo-barrel domain of MSL3
might be involved in the binding of methylated residues as
the aromatic residues required for coordination of methyl-
ated lysines are conserved in MSL3. However, mutations in
two of the conserved hydrophobic residues in MSL3
chromo-barrel domain do not lead to any visible functional
consequences in flies, suggesting that there is no binding in
vivo or that additional residues might contribute to the
interaction (Buscaino et al. 2006). What residue could be
recognized by MSL3 is still a matter of speculation.
Histone H3 lysine 36 (H3K36) is a likely candidate because
the chromodomain of EAF3, the yeast homologue of
MSL3, has recently been shown to bind this modification
(Carrozza et al. 2005; Joshi and Struhl 2005; Keogh et al.
2005). However, experimental evidence for such an
interaction by MSL3 chromo-barrel domain is still lacking.
It would indeed be an interesting possibility if another
histone modification in addition to H4K16Ac would
contribute to the X-chromosomal epigenetic code.
Deletion analysis of different domains that contribute to
the function of MSL3 brought some unexpected insights
about the complexity of dosage compensation (Buscaino et
al. 2006; Morales et al. 2005). MSL3 contains an MRG
domain (MORF4-related gene family) that is found
throughout eukaryotes from yeast to humans, with an
unknown function (Bertram and Pereira-Smith 2001). This
domain is required for proper targeting and integration of
MSL3 into the MSL complex on the X chromosome
Fig. 2 MSL proteins are enriched
on the male X chromosome.
Polytene chromosomes from the
male third instar larvae were
immunostained with antibodies
against MSL3 (green)a n dM S L 2
(orange). DNA is visualized by
Hoechst (blue). The figure illus-
trates that MSL proteins specifi-
cally recognize and colocalize on
hundreds of sites on the male X
chromosome
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achieve dosage compensation because the chromo-barrel
domain is essential for dosage compensation (Buscaino et
al. 2006). Hence, the process of dosage compensation
contains at least two functionally distinct stages—firstly,
recruitment and targeting of the MSL complex to the X
chromosome, and secondly, stimulation of X-linked gene
expression (Buscaino et al. 2006).
The multifunctionality of MSL3 illustrates some of the
complexities that are involved in the mechanism of dosage
compensation. While MOF and MSL3 contain domains
clearly involved in chromatin regulation, the role of MSL1
and MSL2 in chromatin regulation is more enigmatic.
These proteins interact directly through conserved motifs in
the N terminus of MSL1 (Copps et al. 1998). Moreover, the
N terminus is also required for the binding of MSL1 to the
male X chromosome in vivo and for MSL1 self-association
in vitro (Li et al. 2005). Potential MSL1 self-association
introduces a perspective that favors a structure-mediated
function of the MSL complex. This view is further
supported by live cell photo-bleaching experiments with
GFP-MSL2, which suggest an extraordinary stable associ-
ation of MSL2 with the X chromosome (Straub et al. 2005).
Consequently, the MSL complex might not be a classical
chromatin remodeling complex because at least some of its
components do not exhibit the high mobility typical for
other chromatin remodeling complexes. It remains possible
that stable and specific association of MSLs on X-
chromosomal genes induces a specific chromosomal con-
figuration, which is particularly permissive to increased
and/or regulated transcription.
In summary, the characterization of various domains in
MSL proteins suggests a role of the MSL complex at more
than one level of chromatin regulation. However, the
existence of an X-chromosomal epigenetic code remains a
pure speculation because the specific interactions between
chromatin modules and corresponding histone modification
have not been found yet.
Walking on the X—tracking the footsteps of MSLs
For many years, one of the major questions about dosage
compensation in Drosophila has been how MSLs specifi-
cally recognize the X and what are the binding sites of the
MSL complex on the X chromosome. This is of general
interest because there is no simple X-chromosomally
specific DNA sequence that could explain the preference
of MSLs for the X instead of autosomes. Polytene
chromosome spreads have provided a formidable system
for visualization of MSL binding on the male X chromo-
some (Fig. 2). Hundreds of distinct bands bound by the
Fig. 3 Domains in MSL com-
plex members. Schematic
representation of domain orga-
nization in MSL complex mem-
bers (not drawn to scale)
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MSL complex members
(domains/motifs)
Functions and interactions References
MSL-1 (1039aa): basic motif, acidic
region, coiled coil, PEHE motif
Protein region 85–186-aa required for interaction with
MSL-2 RING finger
Copps et al. 1998
N terminus of MSL-1 required for X-chromosome
binding and MSL-1 self-association
Li et al. 2005
C terminus interacts with MOF in vivo. Scott et al. 2000
A 84-aa N-terminal deletion that still interacts with MSL-2,
fails to localize to the X, and causes male lethality.
Scott et al. 2000
MSL-1 is unstable in MSL-2 mutants, and it is stabilized
in MSL-2 overexpressing females.
Chang and Kuroda 1998
PEHE motif essential for binding to MOF in vitro Morales et al. 2004
MSL-2 (773aa): RING finger,
coiled coil
MSL-2 RING finger required for interaction with MSL-2
and male viability
Copps et al. 1998
Various critical RING finger point mutants fail to rescue msl-2 flies. Lyman et al. 1997
Sex lethal binds 3′ and 5′ MSL-2 mRNA and inhibits MSL-2
translation in females.
Bashaw and Baker 1997;
Kelley et al. 1997;
Gebauer et al. 2003
Ectopic MSL-2 expression causes lethality in females that is
dependent on MSL-1 levels.
Kelley et al. 1995
MSL-3 (512aa): chromo-barrel
domain, MRG domain
Chromo-barrel domain binds RNA in vitro. Akhtar et al. 2000
Chromo-barrel domain is required for dosage compensation
but for targeting of the DCC.
Buscaino et al. 2006;
Morales et al. 2005
MSL-3 associates with roX2 RNA in Schneider cells. Buscaino et al. 2003
MSL-3 is acetylated by MOF in vitro and in vivo. Buscaino et al. 2003
DCC binds only to high-affinity sites in MSL-3 mutants. Lyman et al. 1997
MRG domain is required for DCC targeting and assembly. Buscaino et al. 2006;
Morales et al. 2005
MSL-3 interacts directly with MOF and stimulates its HAT activity. Morales et al. 2004
MOF (827aa): chromo-barrel
domain, zinc finger, HAT domain
HAT domain point mutant causes male-specific lethality. Hilfiker et al. 1997
HAT domain required for specific acetylation of H4k16Ac Smith et al. 2000;
Akhtar and Becker 2001
Only enzymatically active MOF activates transcription in vitro. Akhtar and Becker 2000
Chromo-barrel domain binds RNA in vitro. Akhtar et al. 2000;
Nielsen et al. 2005
C2HC zinc finger required for nucleosome binding in vitro Akhtar and Becker 2001
MOF associates with roX2 in vivo in Schneider cells. Akhtar et al. 2000;
Mendjan et al. 2006
MLE (1293aa): dsRNA-binding
domain, helicase domain
Helicase activity on RNA: RNA, RNA: DNA, and DNA:
DNA hybrids
Lee et al. 1997
ATPase activity and DExD box important for male viability Richter et al. 1996
ATPase activity required for complex spreading along the X Lee et al. 1997;
Gu et al. 2000
Helicase activity essential for roX RNA stability Gu et al. 2000
roX2 associates with MLE in vivo. Meller et al. 2000
The C terminus (941–1293-aa) can associate with chromatin
in an RNAse-sensitive manner.
Richter et al. 1996
No action potential (nap) allele of MLE required for mRNA
processing of para
Reenan et al. 2000
roX1/roX2 (3.7 kb/0.6 kb):
roX1 stem loop
In roX1/roX2 double mutants, the DCC is not properly targeted
to the X.
Meller and Rattner 2002
MSL-1 and MSL-2 overexpression partially rescues male
lethality in roX mutants.
Oh et al. 2003
Stem loop in roX1 important for roX1 function Stuckenholz et al. 2003
roX2 variable splicing influences DCC assembly on the X chromosome. Park et al. 2005
Approximately 10% deletions of roX1 do not affect roX function Stuckenholz et al. 2003
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specific antibodies against MSL proteins or roX1/2 RNA
fluorescence in situ hybridization (Kuroda et al. 1991;
Meller et al. 1997). Two of these sites are roX1 and roX2
genomic loci that are bound strongly by the MSL complex.
Initially, it was proposed that these are sites of MSL
complex assembly, which then further spreads in cis over
other binding sites on the X chromosome (Kelley et al.
1999). The characterization of translocations of X frag-
ments to autosomes has led to an alternative model
proposing sites on the X chromosome with different
affinities for the MSL complex (Fagegaltier and Baker
2004; Oh et al. 2004). The affinity model suggests that
there is an X-specific hierarchy of binding affinities for
MSL proteins. In addition, there is also a clear hierarchy in
complex assembly on the X chromosome that distinguishes
MSL1 and MSL2 as essential for further binding of other
complex components (Lucchesi et al. 2005). Consequently,
specific MSL recruitment to the X chromosome seems to be
a complex interplay between different cis- and trans-acting
factors. MSL proteins appear to have intrinsic affinity for
X-chromosomal sequences, which is tightly balanced with
their expression levels and interaction with roX RNAs, as
demonstrated by the observations that overexpression of
MSL1 and MSL2 complex can partially rescue male
lethality in the absence of roX RNAs (Oh et al. 2003; Park
et al. 2002).
The identification of MSL binding sites in more detail
required sophisticated mapping approaches because poly-
tene chromosomes, although very useful, provide limited
resolution at the molecular level. The development of
functional genomic approaches like chromatin immunopre-
cipitation coupled with DNA microarrays (ChIP-chip)
finally allowed the assessment of this question on a global
scale. Previous ChIP experiments suggested that the
complex binds some dosage-compensated genes in the 3′
coding region, but the question remained whether this also
had a global significance (Smith et al. 2001). Three recent
studies reported the binding pattern of MSL proteins on the
X chromosome using various experimental platforms
(Alekseyenko et al. 2006; Gilfillan et al. 2006; Legube et
al. 2006). These studies, consistent with earlier observa-
tions, revealed the preference of the MSL complex to bind
to gene coding regions and in particular to the 3′ end of
genes (Alekseyenko et al. 2006; Gilfillan et al. 2006). It is
interesting to note that studies comparing the binding
profiles of MSL1 in embryos and larvae showed that the
binding pattern of MSL1 does not dramatically change at
different stages of development (Kotlikova et al. 2005;
Legube et al. 2006). This is consistent with the additional
finding that preferential targets of the MSL binding might be
housekeeping/essential genes that are generally expressed
throughout fly development (Gilfillan et al. 2006).
Another intriguing question was whether MSL complex
binding coincides with RNA polymerase II (RNA-PolII)
activity on X-linked genes. Recent observations suggest a
weak or no significant correlation between transcription
and MSL complex binding, at least, in salivary glands
(Kotlikova et al. 2005; Legube et al. 2006). However,
correlation of MSL binding with the active state of gene
expression in embryos and different Drosophila cell types
was indeed observed (Alekseyenko et al. 2006; Gilfillan et
al. 2006; Legube et al. 2006). It is therefore likely that
tissue-specific differences may influence binding of MSL
complex on the X chromosome and that may also in turn be
influenced by the expression status of the X-linked genes
(Sass et al. 2003). Clearly, the mode of X-chromosomal
recognition by the MSL complex is not simple and probably
involves multiple steps. Transcription or degenerate DNA
elements or subchromosomal context may all contribute
to the X-chromosomal specificity of the MSL complex.
MSLs are not alone—the MSL complex meets other
nuclear factors
In 1965, Mukherjee and Beermann analyzed RNA synthe-
sis along the male polytene X chromosome by H
3 uridine
incorporation and observed increased transcription in
comparison to female X chromosomes (Mukherjee and
Beermann 1965, 1966). This was the first direct evidence
suggesting a role of transcription in dosage compensation.
However, despite continuous efforts to discover the
components and mechanism of dosage compensation, the
question is yet unresolved as to how the MSL complex
might impact on transcription.
Our knowledge about the various single components of
the MSL complex does not explain how the specific
twofold transcriptional upregulation is achieved. We know
that the upregulation is dependent on the MSL complex,
but a direct link to the basal machinery that modulates gene
expression is missing. One possibility could be that there is
no such direct link. The mechanism of dosage compensa-
tion could involve novel functions affecting general
chromatin configuration in a unique manner. The other
possibility is that the MSL complex contains or interacts
with additional general factors that would make the link to
established regulatory chromatin transcription systems.
Various levels of chromatin organization are potential
regulation points for the mechanism of dosage compensa-
tion. There are several reported cases that link the MSL
complex to other chromatin-regulating activities/factors.
Firstly, there is the JIL1 histone kinase that has been
reported to interact with the MSL complex and enriches the
X chromosome for H3S10 phosphorylation (Jin et al.
2000). This histone mark has been implicated in chromatin
100 Chromosoma (2007) 116:95–106condensation during mitosis and transcription activation,
but which of these roles relates to its function in dosage
compensation is unclear (Johansen and Johansen 2006). A
recent study further suggests a direct involvement of JIL-1
in dosage compensation of genes on the X chromosome
(Lerach et al. 2005).
The second possible connection between dosage com-
pensation and general modulators of chromatin state is the
chromatin remodeling factor ISWI. In iswi mutant male
larvae, the X chromosome appears puffed, and this
phenotype can be suppressed by a mutation in mle (Corona
et al. 2002). In addition, acetylation at H4K16 by MOF in
vitro inhibits binding of ISWI to chromatin templates
(Clapier et al. 2001). Accordingly, it has been suggested
that there is a balance between ISWI and MSL complex
components, which ensures proper chromatin configuration
of the X chromosome (Corona et al. 2002). Recent studies
suggest a role of the general chromatin factors such as
GAGA, Su(var)3–7, and HP-1 in structure maintenance of
the X chromosome and in dosage compensation (Greenberg
et al. 2004; Spierer et al. 2005).
As discussed above, the MSL complex can be genetically
and functionally linked to various general chromatin factors.
However, a direct biochemical link of such factors to MSL
complex components nor their connection to the mechanism
of dosage compensation has not been shown. The recent
biochemical purification of the Drosophila and human MSL
complexes was therefore bringing some new complemen-
tary insights (Mendjan et al. 2006; Smith et al. 2005).
The purification of the Drosophila MSL complexes via
tagged MOF and MSL3 proteins leads to a number of
unexpected observations. The first surprise was that the
purifications did not contain some of the expected suspects
like MLE, JIL-1, or ISWI. Weak interactions and/or
unfavorable purification conditions may be the reason for
their absence. The second surprise was that none of the
classical transcription-associated factors was found associ-
ated with MOF or MSL3. Instead, there seems to be a core
MSL complex (containing MSL1, MSL2, MSL3, and
MOF) that copurifies with nuclear pore components or
associated proteins (Mtor, Nup153, Nup160, Nup98, and
Nup154), interband binding proteins (Z4, Chromator/
Chriz), and exosome components (Rrp6, Dis3) as well as
a number of novel interaction partners. It is interesting to
note that of the several proteins tested in this study, only the
depletion of nuclear pore associated proteins Mtor and
Nup153 by RNA interference led to the loss of both
classical immunostaining of MSL proteins on the X
chromosome and dosage compensation of at least a subset
of X-linked genes (Mendjan et al. 2006). To date, these
proteins are unique, apart from the MSLs themselves, in
showing such a severe reduction of MSL staining on the X
chromosome as a result of their depletion.
The mechanism of dosage compensation—many hints
but no clear answers
Despite much progress in our understanding of MSL
interactions with each other or the male X chromosome, it
remains a major challenge to decipher the mechanism by
which the MSL complex affects gene expression. It has
become increasingly clear that dosage compensation involves
multiple steps that need to be characterized. The first step
comprises the specific recruitment of the MSL complex to the
X chromosome. To date, no simple DNA element that would
make the X chromosome easily distinguishable from auto-
somes and allow specific binding of MSLs has been found
(Alekseyenko et al. 2006; Dahlsveen et al. 2006; Gilfillan et
al. 2006;L e g u b ee ta l .2006). This, however, does not mean
that the DNA component of chromatin has no role in MSL
complex recruitment. Advanced bioinformatic analysis of the
X chromosome might lead to the discovery of more complex
DNA sequence information that gives some specificity to the
X chromosome. In addition, the epigenetic state, specific
chromatin configuration, transcription, and degenerated
DNA elements could in some combination give the signal
for MSL binding.
The second step of dosage compensation is the twofold
upregulation of gene expression on the male X (Fig. 4a).
Could the histone modification by MOF be the key to the
mechanism of dosage compensation? Acetylation of
H4K16 by MOF has been shown to cause derepression of
transcription either in an in vitro transcription system or
when tethered to a reporter gene in yeast; however, the
effects were more than twofold in these systems (Akhtar
and Becker 2000). There is a possibility that all the other
complex components solely help to target and correctly
distribute MOF at the X chromosome, while H4K16
acetylation does the actual job. How could this be
achieved? The histone code hypothesis predicted correctly,
in some cases, that specific effector proteins bind distinct
marks (Jenuwein and Allis 2001; Strahl and Allis 2000).
However, the receptor (possibly a bromodomain-containing
protein) for H4K16Ac has not been found yet. The local
distribution of this mark and MSL proteins along gene
coding regions implies transcription elongation as a
possible regulation point (Alekseyenko et al. 2006; Gilfillan
et al. 2006; Legube et al. 2006; Smith et al. 2001). These
data are in agreement with the current model of dosage
compensation that implies a role of the MSL complex in
facilitating transcription elongation (Fig. 4a) (Henikoff and
Meneely 1993; Smith et al. 2001). In general, histone
acetylation has been already suggested to enhance tran-
scription, but this has not been specifically demonstrated
for the H4K16 mark (Orphanides and Reinberg 2000;
Svejstrup 2002). It is important to note however that the
H4K16 residue is directly implicated in higher-order
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al. 2003; Shogren-Knaak et al. 2006; Shogren-Knaak and
Peterson 2006). Thus, the effect of H4K16 modification
that ultimately leads to dosage compensation may involve
levels of chromatin organization and function, which are
still poorly understood.
The local enrichment of MSLs at the 3′ end of genes
supports the transcription elongation model (Fig. 4a);
however, the mere presence of MSL proteins at the 3′ end
of genes is not sufficient to explain mechanistically how
MSLs might help facilitate efficient elongation. Integration
of the recent data concerning copurification of nuclear pore
components and exosome components with MSL proteins
into the elongation model of dosage compensation may
help to conceptualize how this might be achieved (Fig. 4b).
One model, drawn from analogies to yeast, is that
nuclear pore components may influence dosage compensa-
tion through chromatin loop organization and spatial
positioning (Casolari et al. 2005; Feuerbach et al. 2002).
Mtor and Nup153 in Drosophila Schneider cells could
affect specific gene or chromosomal domain organization
that is required for subsequent mechanisms of chromatin
regulation (Fig. 4b, model 1). This model implies that Mtor
and Nup153 are indirectly involved in the upregulation of
transcription by participating in a higher hierarchical level
of chromatin organization and compartmentalization. How
important this aspect can be for optimal gene expression
was nicely demonstrated in yeast for galactose-inducible
genes that require association with the nuclear pore for
optimal induction (Cabal et al. 2006; Taddei et al. 2006). It
is interesting to note that for HKX1 gene, localization to the
nuclear periphery required sequences at the 3′ end of the
gene (Taddei et al. 2006). There are some intriguing
parallels with enriched binding of MSL complex also at
the 3′ end of genes (Alekseyenko et al. 2006; Gilfillan et al.
2006; Smith et al. 2001). However, the significance of this
enrichment remains to be explored.
The second model is that Mtor/Nup153 might have a
more direct role on gene expression machinery by linking
X-chromosomal transcripts and regulatory exosome com-
ponents (Fig. 4b, model 2). Most of the data concerning the
role of the exosome in RNA surveillance, coupling with
transcription elongation, and collaboration with Mlp/Mtor
have been obtained in yeast (Sommer and Nehrbass 2005).
The exosome components Rrp6 and Dis3 participate at
different steps of mRNA maturation, and they collaborate
with the Mlps at essential steps of gene expression (Galy et
al. 2004). Recent work has linked the exosome (Rrp6
subunit) to the TREX complex that is thought to couple
transcription with export (Libri et al. 2002; Zenklusen et al.
2002). Moreover, the exosome is recruited to active genes
through interactions with transcription elongating factors
(Andrulis et al. 2002). The Rrp6 subunit has been
implicated in quality control of mRNP particles already at
a very early step during transcription (Casolari et al. 2004;
Hilleren et al. 2001; Libri et al. 2002). The factors that
ultimately link the exosome and Mlp proteins are not
known in yeast, and whether the MSLs might fulfill this
function in Drosophila is a matter of speculation.
What would be the role of the MSL proteins in this
context? At least three MSLs (MOF, MSL3, and MLE)
have been shown to bind RNA (Akhtar et al. 2000;
Buscaino et al. 2003; Richter et al. 1996). In addition,
two of them (MOF and MSL3) copurify Mtor, suggesting
that they could have a mediating role between chromatin,
transcription, and pre-mRNA processing. There is a
possibility that cotranscriptional pre-mRNA processing
represents the point of MSL regulation. The MSL complex
could specifically facilitate spatial, cotranscriptional cou-
pling between events in gene expression of X-chromosomal
genes. The exosome is involved in the processing and
Fig. 4 Dosage compensation working models. a The current
predominant model of dosage compensation proposes transcription
elongation as the main regulating point of the MSL complex. How this
is achieved on the molecular level and what is the role of H4K16
acetylation is not yet known (represented by a question mark).
H4K16Ac is represented by asterisk, while nucleosomes are repre-
sented by gray circles. MSL complex and RNA PolII are represented
by purple and orange ovals, respectively. X-chromosomal transcript is
represented by gray wiggled line. b MSL proteins are enriched on the
3′ end of X-linked genes, and they have been found to be associated
with components of the nuclear pore complex (NPC) (Alekseyenko et
al. 2006; Gilfillan et al. 2006; Mendjan et al. 2006; Smith et al. 2001).
Consequently, speculative models for the molecular mechanism of
dosage compensation can be envisaged that could stimulate our
thinking about how MSLs might affect transcription elongation.
Model 1 proposes that MSL–NPC interactions might create a
specialized X-chromosomal compartment or domain. This model is
based on observations in yeast, where the orthologue of Mtor (Mlp1)
has been shown to bind transcriptionally active genes (Casolari et al.
2005). Furthermore, transcriptional activity of a gene has the potential
to be modulated at the nuclear periphery (Cabal et al. 2006; Taddei et
al. 2006). In manner similar to yeast, nuclear pore components in
Drosophila may also facilitate modulation of transcriptional activity.
This can be achieved by organizing chromatin into functional
domains. The X chromosome may therefore require such organization
to create functional territories where the MSL complex can act
cooperatively to regulate the expression of many X-linked genes.
Model 2 proposes that MSLs may link the X chromosome with the
nuclear exosome and the NPC and therefore facilitate coupling of
transcription elongation and posttranscriptional events such as RNA
processing or export. Another interesting possibility is that nuclear
pore components like Mtor and/or Nup153 might be involved in
efficient processing and maturation of roX RNAs and their efficient
incorporation into the MSL complex. The question remains whether
these effects are really a consequence of physical tethering of
chromatin and/or RNA to the pore or whether dynamic behavior of
pore components facilitates such interaction and therefore does not
need to occur at the pore. Model 3 therefore suggests a nuclear pore
independent function of Mtor and Nup153 in gene regulation. The
models 1–3 are not mutually exclusive, and depending on the
circumstance, one or more modules may contribute to fine tune gene
activity

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Zenklusen et al. 2002). Consequently, it might also be
required for processing and subsequent assembly of roX
RNAs into the MSL complex. roX2 RNA has been shown
to undergo variable splicing that contributes to its function
in dosage compensation (Park 2005), raising the possibility
that other roX RNA processing events might also be
critical. It is also interesting to note that a recent study
demonstrated the importance of exosome components for
Xist RNA processing that is essential for proper X-
chromosome inactivation in mammals (Ciaudo et al.
2006). Future studies on roX RNA processing might
Chromosoma (2007) 116:95–106 103uncover another interesting parallel between the dosage
compensation systems in Drosophila and mammals.
Finally, it can be envisaged that nuclear pore complex
members may also function outside of their predominant
role as members of the nuclear pore and act as independent
submodules for regulating gene activity (Fig. 4b, model 3).
Consistent with this hypothesis, a number of nuclear pore
components have been shown to display dynamic behavior
or exist as soluble pools in the nucleoplasm (Cordes et al.
1997; Griffis et al. 2002, 2004; Hase and Cordes 2003;
Hase et al. 2001; Rabut et al. 2004; Zimowska et al. 1997).
In this scenario, limited soluble pools of these proteins may
bind genic or intergenic regions to function as activators or
repressors and in this capacity affect X-chromosomal as
well as autosomal gene expression. It is important to note
that neither of the above scenarios is mutually exclusive,
and combined action of different steps may result in the
twofold impact on transcription.
In summary, recent studies have made important
advances in our knowledge of dosage compensation in
Drosophila. They highlight the complexity behind the
twofold upregulation of transcription and various levels of
chromosomal regulation and gene expression control that
might participate in it. One thing is clear: the dosage
compensation process will continue to fascinate us for quite
sometime to come.
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